Oyibo References 1.Diabetes-type 2: prevalence
So I think theres a concern here that, if you start prescribing this, for addiction that there will be a point in which when theyre no longer on the a, the medications that their cravings for cocaine or alcohol or heroin, you name it will return and thats a concern because if you have stopped using a substance as powerful as heroin for a period of time and then you end up going back to it, then your tolerance is much reduced and your risk of overdose is much, much higher
INTERNATIONAL ROUNDUP (PharmaTimes, March 9-14) Regulatory Approvals: MHRA approved deuruxolitinib for severe alopecia areata NHS to offer fezolinetant for menopause hot flushes Clinical Trials: Aplagon dosed first patient in phase 2a peripheral arterial disease trial UCB reported bimekizumab superiority in psoriatic arthritis Kainova reported positive phase 1 data for DT-9081 in advanced solid tumours EnteroBiotix completed enrolment for EBX-102-02 trial in microbiome therapy Industry Appointments: Dr Michelle Morrow appointed CSO at Nucleome Dr Klaas Zuideveld named CEO at TECregen Rebecca Simmons appointed COO at Qureight KEY DATA POINTS SUMMARY Metric Value GLP-1 sales (MAT Feb 2026) 1,446 crore (177%) Stranded containers 40,000-45,000 Export cargo affected $1-1.5 billion War surcharge per container $3,000-5,000 Glycerin price increase 64% (Dec-Mar) Paracetamol API increase 26% (Dec-Mar) Polypropylene price increase 55/kg (since Dec) Universal NutriScience valuation 3,000 crore API exports (FY25) 41,500 crore API imports (FY25) 39,215 crore ABOUT THE INDIAN PHARMACEUTICAL INDUSTRY India is the "pharmacy of the world," supplying over 60% of global vaccine demand and 40% of generic medicines in the US
Some patients benefit from taking their dose on a full stomach or pairing medication with a salt-containing meal
By contrast, symmetric cell division occurs once satellite cells are activated and generates one type of cell (either two self-renewing stem cells or two differentiating cells)
